SCOR (FR:SCR)
:SCR
Want to see FR:SCR full AI Analyst Report?
SCR Stock Chart & Stats
€32.86
-€0.20(-0.80%)
At close: 4:00 PM EST
€32.86
-€0.20(-0.80%)
Day’s Range― - ―
52-Week Range€25.30 - €33.48
Previous CloseN/A
Volume67.17K
Average Volume (3M)449.32K
Market Cap
€5.70B
Enterprise Value€7.61B
Total Cash (Recent Filing)€21.55B
Total Debt (Recent Filing)€3.57B
Price to Earnings (P/E)6.1
Beta1.17
Next Earnings
Jul 30, 2026EPS Estimate
1.02Next Dividend Ex-DateN/A
Dividend Yield6.35%
Share Statistics
EPS (TTM)4.76
Shares Outstanding179,389,980
10 Day Avg. Volume549,487
30 Day Avg. Volume449,316
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.16
Price to Sales (P/S)0.32
P/FCF Ratio5.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€34.46Price Target Upside4.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)4.34
Revenue Forecast (FY)€15.72B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthConsistent operating cash flow and ~€1.0B free cash flow in 2025 provide durable internal funding to pay claims, support dividends and capital actions, and give management flexibility to invest in underwriting capacity or buy protection in stressed cycles, cushioning volatility.
Diversified P&C And Life & Health FranchiseA business model spanning P&C and L&H spreads exposure across distinct underwriting cycles and risk pools, helping stabilize earnings over time. This diversification enables cross-line expertise, better client solutions, and the ability to allocate capital where returns are strongest across cycles.
Manageable Leverage And Balance Sheet CapacityModerate debt and a reasonable debt-to-equity range signal available balance sheet capacity typical for reinsurers, supporting the ability to underwrite large risks and to absorb catastrophe shocks without immediate recapitalization, preserving strategic optionality over months.
Bears Say
Volatile Profitability And Underwriting ResultsSharp swings from large underwriting losses to rebounds indicate earnings are sensitive to catastrophe and reserve experience. This volatility undermines predictability of returns and capital generation, complicating multi-quarter planning for underwriting limits and reinsurance purchasing.
Equity And ROE InconsistencyDeclining equity and uneven ROE reduce the firm’s capital buffer and make capital planning harder. Persistent swings in retained earnings can limit organic growth, increase the chance of external capital raises at unfavorable times, and pressure ratings or pricing power.
Uneven Revenue TrendNegative multi-period revenue growth highlights sensitivity to pricing cycles and client demand. Even with a return to growth in 2025, uneven top-line trends make forecasting underwriting scale harder and may reflect exposure to competitive pricing or lumpy treaty renewals that persist over several quarters.
SCOR News
SCR FAQ
What was SCOR’s price range in the past 12 months?
SCOR lowest stock price was €25.30 and its highest was €33.48 in the past 12 months.
What is SCOR’s market cap?
SCOR’s market cap is €5.70B.
When is SCOR’s upcoming earnings report date?
SCOR’s upcoming earnings report date is Jul 30, 2026 which is in 71 days.
How were SCOR’s earnings last quarter?
SCOR released its earnings results on May 06, 2026. The company reported €1.23 earnings per share for the quarter, beating the consensus estimate of €1.091 by €0.139.
Is SCOR overvalued?
According to Wall Street analysts SCOR’s price is currently Undervalued.
Does SCOR pay dividends?
SCOR pays a Annually dividend of €1.8 which represents an annual dividend yield of 6.35%. See more information on SCOR dividends here
What is SCOR’s EPS estimate?
SCOR’s EPS estimate is 1.02.
How many shares outstanding does SCOR have?
SCOR has 179,389,980 shares outstanding.
What happened to SCOR’s price movement after its last earnings report?
SCOR reported an EPS of €1.23 in its last earnings report, beating expectations of €1.091. Following the earnings report the stock price went up 6.473%.
Which hedge fund is a major shareholder of SCOR?
Currently, no hedge funds are holding shares in FR:SCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SCOR
SCOR SE, together with its subsidiaries, provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and Asia Pacific. It operates through two segments, SCOR Global P&C and SCOR Global Life. The SCOR Global P&C segment offers reinsurance products in the areas of property, motors, casualty treaties, credit and surety, decennial insurance, aviation, marine and energy, engineering, agricultural risks, and property catastrophes; specialties insurance products, including business solutions, political and credit risks, cyber, and environmental impairment liability; and business ventures and partnerships. The SCOR Global Life segment provides life reinsurance products, including protection for mortality, morbidity, behavioral risks, disability, long-term care, critical illness, medical, and personal accident. This segment also provides financial solutions that combine traditional life reinsurance with financial components and provide liquidity, balance sheet, solvency, and income improvements to clients; longevity solutions that include products covering the risk of negative deviation from expected results due to the insured or annuitant living longer than assumed in the pricing of insurance covers provided by insurers or pension funds; and distribution solutions. In addition, it is involved in the asset management business. The company was founded in 1970 and is headquartered in Paris, France.
SCR Stock 12 Month Forecast
Average Price Target
€34.46
▲(4.86% Upside)
Technical Analysis
Options Prices
Currently, No data available
---